Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Discover how U.S. trade tariffs and proposed Medicaid cuts could reshape workers’ comp costs and care access. Dave Torrence outlines key risks and strategies in WorkCompWire’s "Leaders Speak" article.
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp. Discover what this breakthrough could mean for pain management and claims strategies.
The Implications of Trump's Health Care Executive Order for Workers' Compensation and Auto Insurers
4 MIN READ
Explore the immediate effects of President Trump's 2025 health care executive order on workers' compensation and auto insurers, including rising drug costs and supply chain disruptions.
Ask The Pharmacist: Bird Flu and Its Growing Impact on Public Health
3 MIN READ
Bird flu, or avian influenza, is an emerging public health and industry concern across North America. While the virus primarily affects birds, it can occasionally spread to humans—raising important questions around occupational exposure and public health safety.
From Setback to Comeback: Effective Solutions for Delayed Recovery
1 MIN READ
Learn how to effectively ignite workers' compensation recovery by addressing some of the biggest return-to-work obstacles, including mental health comorbidities, social factors, and delayed intervention. See how data-driven strategies lead to successful claims management and faster employee recovery.
Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain
3 MIN READ
The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in adults. This approval, announced on January 30, 2025, marks a significant milestone in pain management, introducing the first new class of oral medication for acute pain in over two decades.
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Nikki Wilson examines Journavx, a new FDA-approved nonopioid pain medication, and its potential impact on workers' compensation as a safer alternative to opioids for acute pain management.